Big tech moves fast. Sometimes it moves too fast, and things just... break. That’s basically the story of the Amazon fertility tracker project shutdown, a quiet end to an ambitious attempt to own the "femtech" space. While Amazon is usually the king of logistics and cloud computing, navigating the messy, highly personal world of reproductive health turned out to be a different beast entirely. It wasn't just about the tech; it was about trust, timing, and a market that was already getting pretty crowded.
Amazon doesn't usually like to admit defeat. They’d rather pivot. But with this project, which was internally codenamed "Encore," the retail giant decided to pull the plug before it even really hit the mainstream.
The Secret Life of Project Encore
The project was tucked away inside Grand Challenge, Amazon’s secretive moonshot lab. Think of it like Google X, but for Jeff Bezos's empire. This group was tasked with finding the next "big thing" that wasn't just a better way to ship a box of laundry detergent. They wanted to solve hard problems. According to reporting from CNBC and internal leaks that surfaced over the last couple of years, the team was developing a device that could predict a woman's fertile window by testing saliva.
It sounds cool, right? No more peeing on sticks or checking basal body temperature every single morning before you even move your head off the pillow.
The goal was simple: use a high-tech sensor to detect changes in estrogen and luteinizing hormone (LH) through a simple mouth swab. But simple on paper is a nightmare in hardware. Sensors that are sensitive enough to pick up tiny hormonal shifts in saliva are notoriously finicky. They require calibration. They require a level of precision that is hard to mass-produce at a price point people will actually pay.
Then there’s the competition. Companies like Oura, Ava, and Natural Cycles were already light-years ahead in terms of user trust. Amazon was playing catch-up in a game where the rules were changing every day.
Why the Amazon fertility tracker project shutdown wasn't a surprise
Honestly, if you look at Amazon’s track record with health hardware, the writing was on the wall. Remember the Amazon Halo? That weird wristband that didn't have a screen and told you if you sounded "dismissive" to your spouse? Yeah, that got killed too.
👉 See also: iPhone 16 Pink Pro Max: What Most People Get Wrong
Amazon has a "fail fast" culture. They throw a hundred things at the wall, and if ninety-nine of them don't stick, they don't lose sleep over it. The Amazon fertility tracker project shutdown happened because the ROI just wasn't there. Developing medical-grade hardware is expensive. Really expensive. You have to deal with the FDA. You have to deal with clinical trials. You have to prove, beyond a shadow of a doubt, that your device isn't going to give someone a false positive—or worse, a false negative—when they’re trying to plan their family.
The Privacy Elephant in the Room
We have to talk about the data. After the Dobbs decision in the United States, people became—rightfully—terrified of how their period and fertility data was being tracked.
Imagine a company that already knows what you buy, what you watch, and what you say to your smart speaker also knowing exactly when you're ovulating. It’s a lot. Even if Amazon promised the data was encrypted and "siloed," the optics were terrible. Consumers started looking for "local-first" data storage or companies with a dedicated focus on privacy. Amazon is a data company. That’s their whole brand. Trying to convince a skeptical public that their most intimate biological data was safe from the "everything store" was an uphill battle they maybe didn't want to fight anymore.
The Technical Hurdles of Saliva Testing
Let's get nerdy for a second. Most fertility trackers use two main methods:
- Luteinizing Hormone (LH) in Urine: This is the gold standard for home testing (the "OPK" strips you see at CVS). It's accurate because the LH surge is massive right before ovulation.
- Basal Body Temperature (BBT): This tracks the progesterone rise after ovulation. It doesn't predict; it confirms.
Amazon was trying to go for a third way—salivary ferning and hormone detection. The problem is that things like coffee, toothpaste, or even a glass of water can mess with saliva samples. If the user doesn't use the device perfectly, the data is garbage. Garbage in, garbage out. For a company that thrives on "one-click" simplicity, a device that required a complex, multi-step morning routine was a hard sell.
What this means for the future of "Femtech"
The Amazon fertility tracker project shutdown doesn't mean the market is dead. Far from it. In fact, it's a sign that the market is maturing. It shows that consumers aren't just going to buy a health tracker because it has a famous logo on it. They want specialized, dedicated tools from companies that live and breathe health data—not companies that also sell cloud servers and Prime Video subscriptions.
✨ Don't miss: The Singularity Is Near: Why Ray Kurzweil’s Predictions Still Mess With Our Heads
Look at what's winning right now:
- Oura Ring: It uses skin temperature and heart rate variability (HRV) to track cycles. It's passive. You just wear it.
- Apple Watch: They integrated a temperature sensor specifically for cycle tracking.
- Clearblue: They stayed in their lane with digital readers for urine strips that connect to an app.
Amazon realized they couldn't just "disrupt" their way into this. It requires a level of empathy and specific expertise that a generalist tech giant often lacks.
The broader "Grand Challenge" pivot
It's also worth noting that the Amazon fertility tracker project shutdown happened amidst a massive wave of layoffs and cost-cutting at the company. In 2023 and 2024, Amazon slashed thousands of jobs across its "unprofitable" sectors. The Grand Challenge lab was one of the first places the bean counters looked. If a project wasn't on a clear path to generating billions in revenue within a few years, it was gone.
The team working on the fertility tracker was reportedly disbanded or moved to other health-related initiatives, like Amazon Clinic or One Medical. Amazon is still interested in healthcare—they just want to be the platform where you talk to a doctor or buy your meds, not necessarily the hardware manufacturer that tracks your hormones.
Actionable Insights: What should you do now?
If you were waiting for an Amazon-branded solution to manage your reproductive health, you should probably stop waiting. The project is dead, and it's not coming back in its current form.
Instead, focus on these steps to find a solution that actually works for you:
🔗 Read more: Apple Lightning Cable to USB C: Why It Is Still Kicking and Which One You Actually Need
Audit your privacy needs. If you are concerned about data being used for anything other than your own health, look for apps and devices that offer "Anonymous Mode" or local-only storage. Flo and Clue have both made big strides here recently.
Choose your "Why." If you're trying to conceive (TTC), you need a device that predicts. That means LH strips or a high-end monitor like Initio. If you're just trying to understand your body, a wearable like the Oura Ring or the latest Apple Watch is much easier to maintain than a saliva-based sensor ever would have been.
Don't ignore the low-tech stuff. Sometimes, a $15 basal thermometer and a paper chart are more reliable than a $300 gadget from a tech company that might lose interest in the project in eighteen months.
Check the clinical backing. Before buying any new fertility tech, search for their peer-reviewed studies. Real health tech companies publish their data in medical journals. If a company only has "internal data," be skeptical.
Amazon's exit from this specific niche is a reminder that health is hard. You can't just code your way around biology. The Amazon fertility tracker project shutdown is a win for specialized companies and a lesson for big tech: some things are too personal for the "everything store."